BlackRock’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2K | Hold |
25,172
| – | – | ﹤0.01% | 5016 |
|
|
2025
Q1 | $31.7K | Hold |
25,172
| – | – | ﹤0.01% | 4963 |
|
|
2024
Q4 | $57.1K | Sell |
25,172
-2
| -0% | -$5 | ﹤0.01% | 4856 |
|
|
2024
Q3 | $87K | Sell |
25,174
-587
| -2% | -$2.03K | ﹤0.01% | 4646 |
|
|
2024
Q2 | $131K | Sell |
25,761
-6,860
| -21% | -$34.8K | ﹤0.01% | 4583 |
|
|
2024
Q1 | $276K | Buy |
32,621
+1,531
| +5% | +$13K | ﹤0.01% | 4462 |
|
|
2023
Q4 | $127K | Sell |
31,090
-71
| -0.2% | -$291 | ﹤0.01% | 4675 |
|
|
2023
Q3 | $93.5K | Sell |
31,161
-1,203
| -4% | -$3.61K | ﹤0.01% | 4795 |
|
|
2023
Q2 | $1M | Buy |
32,364
+758
| +2% | +$23.4K | ﹤0.01% | 4212 |
|
|
2023
Q1 | $1.56M | Buy |
31,606
+155
| +0.5% | +$7.67K | ﹤0.01% | 4077 |
|
|
2022
Q4 | $774K | Buy |
31,451
+230
| +0.7% | +$5.66K | ﹤0.01% | 4414 |
|
|
2022
Q3 | $2.07M | Sell |
31,221
-361
| -1% | -$23.9K | ﹤0.01% | 4095 |
|
|
2022
Q2 | $1.31M | Sell |
31,582
-52
| -0.2% | -$2.15K | ﹤0.01% | 4339 |
|
|
2022
Q1 | $1.59M | Buy |
31,634
+136
| +0.4% | +$6.85K | ﹤0.01% | 4400 |
|
|
2021
Q4 | $1.89M | Buy |
31,498
+234
| +0.7% | +$14K | ﹤0.01% | 4357 |
|
|
2021
Q3 | $1.55M | Sell |
31,264
-359
| -1% | -$17.8K | ﹤0.01% | 4360 |
|
|
2021
Q2 | $1.8M | Sell |
31,623
-98,593
| -76% | -$5.62M | ﹤0.01% | 4252 |
|
|
2021
Q1 | $7.48M | Buy |
130,216
+2,193
| +2% | +$126K | ﹤0.01% | 3682 |
|
|
2020
Q4 | $8.69M | Buy |
128,023
+3,164
| +3% | +$215K | ﹤0.01% | 3371 |
|
|
2020
Q3 | $31.7M | Buy |
124,859
+984
| +0.8% | +$250K | ﹤0.01% | 2522 |
|
|
2020
Q2 | $20.8M | Buy |
123,875
+98,275
| +384% | +$16.5M | ﹤0.01% | 2726 |
|
|
2020
Q1 | $1.78M | Buy |
25,600
+14,564
| +132% | +$1.01M | ﹤0.01% | 3618 |
|
|
2019
Q4 | $709K | Buy |
11,036
+2,070
| +23% | +$133K | ﹤0.01% | 4033 |
|
|
2019
Q3 | $525K | Buy |
8,966
+281
| +3% | +$16.5K | ﹤0.01% | 4105 |
|
|
2019
Q2 | $514K | Buy |
8,685
+2,679
| +45% | +$159K | ﹤0.01% | 4131 |
|
|
2019
Q1 | $392K | Buy |
6,006
+320
| +6% | +$20.9K | ﹤0.01% | 4083 |
|
|
2018
Q4 | $303K | Buy |
5,686
+15
| +0.3% | +$799 | ﹤0.01% | 4111 |
|
|
2018
Q3 | $325K | Buy |
5,671
+158
| +3% | +$9.06K | ﹤0.01% | 4159 |
|
|
2018
Q2 | $323K | Buy |
5,513
+235
| +4% | +$13.8K | ﹤0.01% | 4151 |
|
|
2018
Q1 | $249K | Sell |
5,278
-312
| -6% | -$14.7K | ﹤0.01% | 4114 |
|
|
2017
Q4 | $328K | Buy |
5,590
+315
| +6% | +$18.5K | ﹤0.01% | 4059 |
|
|
2017
Q3 | $326K | Sell |
5,275
-109
| -2% | -$6.74K | ﹤0.01% | 4065 |
|
|
2017
Q2 | $335K | Buy |
5,384
+246
| +5% | +$15.3K | ﹤0.01% | 4061 |
|
|
2017
Q1 | $327K | Buy |
+5,138
| New | +$327K | ﹤0.01% | 4036 |
|